Obesity and weight management

Percent total body weight loss expresses change in weight as a fraction of starting weight. It is the standard way to monitor and report response to obesity treatment, including GLP-1 and dual incretin therapies. A loss of 5% or more is generally considered clinically meaningful, with greater benefit at 10% and 15% or more. It is a monitoring metric, not a diagnosis.

BMI is weight in kilograms divided by height in metres squared. It is a quick population screen for weight status, not a measure of body fat or health on its own. For people of South Asian and other Asian ancestry, risk rises at lower BMIs, so the lower WHO Asia-Pacific cut points are shown alongside the standard bands.

HOMA-IR is a simple fasting surrogate for insulin resistance derived by Matthews and colleagues in 1985. A healthy reference individual scores about 1; higher values suggest more insulin resistance. There is no single universal threshold: cutoffs vary with the insulin assay, population, age, and BMI, so the number is best read against your own laboratory's reference range and trended over time.

The Mifflin-St Jeor equation estimates resting energy expenditure (the calories burned at rest) from weight, height, age, and sex. Multiplying by an activity factor gives total daily energy expenditure, a starting point for calorie planning in healthy adults.